| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 3O9FA4XC02 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Lymphocyte differentiation antigen CD38 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Multiple Myeloma | 3 | D009101 | ClinicalTrials |
| Glomerulonephritis | 2 | D005921 | ClinicalTrials |
| Kidney Diseases | 2 | D007674 | ClinicalTrials |
| Glomerulonephritis, IGA | 2 | D005922 | ClinicalTrials |
| Lupus Nephritis | 1 | D008181 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 1 | D008180 | ClinicalTrials |
| Glomerulonephritis, Membranous | 1 | D015433 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594579 |
| FDA SRS | 3O9FA4XC02 |
CONTENTS